Pharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal Function

Status:
Completed

Trial end date:
2015-12-01

Target enrollment:

Participant gender:

This study will evaluate the effect of various degrees of renal function on the pharmacokinetics and safety of ALKS 5461.

Phase 1

Alkermes, Inc.